Local News

• Abbott recognized on Dow Jones Sustainability Index (DJSI) for fourth consecutive year  Abbott announced that it was recognized on the Dow Jones Sustainability World Index and the Dow Jones Sustainability North America Index for the fourth consecutive year.
  Abbott September 04, 2008  
• Amgen and Wyeth statement on the FDA Safety Announcement regarding TNF blockers  Amgen and Wyeth Pharmaceuticals issued a statement in response to the Food and Drug Administration (FDA) safety announcement regarding opportunistic fungal infections in patients treated with Tumor Necrosis Factor (TNF) blockers (marketed as Remicade(R), Enbrel(R), Humira(R) and Cimzia(R)).
  Amgen September 04, 2008  
• Percutaneous coronary intervention with CYPHER(R) stent comparable to bypass surgery  Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent was comparable to bypass surgery in key safety endpoints in patients with multi-vessel disease and diabetes.
  Johnson & Johnson September 04, 2008  
• Questcor repurchases 1.8 million common shares from Inverlochy Consultadoria & Servicos  Questcor Pharmaceuticals announced that it has concluded a privately negotiated agreement to repurchase 1,800,000 shares of its common stock at a purchase price of $5.06 per share for a total purchase price of $9,108,000 from Inverlochy Consultadoria & Servicos L.D.A.
  Questcor Pharmaceuticals, Inc. September 04, 2008  
• Isis receives notices of allowance that expands scope of key RNA therapeutic patents  Isis Pharmaceuticals, Alnylam Pharmaceuticals, and the companies' joint venture Regulus Therapeutics announced that the United States Patent and Trademark Office has granted notices of allowance for two U.S. patent applications that further enhance the scope of Isis' "Crooke" patent estate.
  Isis Pharmaceuticals, Inc. September 04, 2008  
• Monsanto's Roundup Ready 2 Yield(TM) Soybeans receive China regulatory approval  Monsanto Company announced it has received regulatory approval in China for the importation of Roundup Ready 2 Yield(TM) soybeans. China imports accounted for approximately 38 percent of U.S. soybean exports in 2007, making it the largest purchaser of U.S. soybeans.
  Monsanto Company September 04, 2008  
• Invitrogen launches patent licensing program for enabling amplification technology  Invitrogen announced that it has signed non-exclusive agreements with New England Biolabs, QIAGEN GmbH, and Kirkegaard & Perry Laboratories whereby the companies have licensed Invitrogen's patented technology covering the random prime amplification of nucleic acids.
  Invitrogen Corporation September 04, 2008  
• Applied Biosystems teams With leaders in CT and NJ to drive stem cell research  Scientists conducting stem cell research are convening at symposia in mid-September in Connecticut and New Jersey to share best practices, drive standardization to advance science, and enable greater collaboration.
  Applied Biosystems September 04, 2008  
• Genomic Health announces publication of a study comparing Oncotype DX and Adjuvant!  Genomic Health announced the publication of positive results from a study indicating that the Oncotype DX(R) Recurrence Score(R) provides additional prognostic information beyond Adjuvant! Online (AO) for breast cancer patients with negative nodes or up to three positive nodes.
  Genomic Health, Inc. September 03, 2008  
• Sangamo BioSciences initiates phase 2 Clinical trial of treatment for ALS  Sangamo BioSciences announced that it has opened a Phase 2 clinical trial (SB-509-801) to evaluate its drug, SB-509, in subjects with ALS, a progressive, degenerative motor-neuron disease for which there are limited treatment options and no cure.
  Sangamo BioSciences, Inc. September 03, 2008  

   (next 10 articles)